-
Subversive Debuts In Israel Via Qualifying Transaction With InterCure
2021 Jan 26, 4:38pm | 276Read More...Subversive Real Estate Acquisition REIT LP (OTCQX: SBVRF) (NEO: SVX.U) is teaming up with Israeli cannabis company InterCure Ltd. “We are excited to announce today’s qualifying transaction, which, upon closing, will allow our shareholders to participate in the upside of the Israeli...
-
Supreme Cannabis Prices Offering At $20M, Taps BMO Capital Markets As Bookrunner
2021 Jan 26, 12:15pm | 215Read More...The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) confirmed the pricing of its earlier announced public offering of units at a price of 19 cents per unit. The underwriters agreed to buy 105.26 million units for gross proceeds of around $20 million. The units will be offered in...
-
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
2021 Jan 26, 8:07am | 2313Read More...Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 25) Abbott Laboratories (NYSE: ABT) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Antares Pharma Inc (...
-
AMC Networks Prices $1 Billion Secured Notes In Upsized Debt Offering
2021 Jan 26, 6:01am | 102Read More...AMC Networks Inc. (NASDAQ: AMCX) announced that it has priced 4.25% senior secured notes due 2029 worth $1 billion in an upsized public offering. The offering was upsized from $500 million proposed earlier that day. AMCX intends to use $1 billion proceeds to redeem 4.75% senior notes due December...
-
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
2021 Jan 22, 7:22am | 1735Read More...Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) Acasti Pharma Inc (NASDAQ: ACST) Alimera Sciences Inc(NASDAQ: ALIM) argenx SE – ADR (NASDAQ: ARGX) Axonics Modulation Technologies Inc (...
-
Why OncoCyte Shares Are Trading Higher Today
2021 Jan 21, 12:45pm | 170Read More...OncoCyte Corp (NYSE: OCX) shares are advancing to their highest level since the middle of 2019 on above-average volume. Oncocyte said it has entered into definitive agreements with its two largest institutional investors, namely Pura Vida Investments and Broadwood Partners, to purchase about $25...
-
Why Celsion's Stock Is Ripping Higher Today
2021 Jan 21, 12:31pm | 128Read More...Celsion Corporation (NASDAQ: CLSN) shares are trading at their highest level since early July after the company terminated a stock sale agreement. Celsion revealed in SEC filing it has notified Lincoln Park Capital Fund regarding termination of the stock purchase agreement signed between both...
-
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
2021 Jan 21, 8:05am | 2804Read More...Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 20) 10X Genomics Inc (NASDAQ: TXG) ABIOMED, Inc. (NASDAQ: ABMD) Aclaris Therapeutics Inc (NASDAQ: ACRS) Adamis Pharmaceuticals Corp(NASDAQ: ADMP...
-
Why Gevo's Stock Is Trading Lower Today
2021 Jan 20, 3:34pm | 113Read More...Gevo (NASDAQ: GEVO) shares are trading lower Wednesday after the company announced a $350 million registered direct offering of common stock. The offering is priced at $8 per share. Gevo is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives...
-
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
2021 Jan 20, 7:32am | 3114Read More...Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 19) 4D Molecular Therapeutics Inc (NASDAQ: FDMT) ABIOMED, Inc. (NASDAQ: ABMD) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) Aclaris Therapeutics Inc (...
-
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
2021 Jan 15, 7:32am | 2795Read More...Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 14) 10X Genomics Inc (NASDAQ: TXG) 4D Molecular Therapeutics Inc (NASDAQ: FDMT) Adaptive Biotechnologies Corp (NASDAQ: ADPT) Aligos Therapeutics Inc (...
-
Crypto-Asset Broker Voyager Digital To Raise $25 Million In Private Placement
2021 Jan 15, 5:53am | 376Read More...Voyager Digital Ltd. (OTC: VYGVF) announced Thursday that it seeks to raise $25 million in gross proceeds from a private placement offer. What Happened: The crypto-asset broker has entered into an agreement with agent Stifel GMP for the $25 million common stock...
-
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
2021 Jan 14, 7:56am | 1836Read More...Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 13) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Atea Pharmaceuticals Inc (NASDAQ: AVIR) Bioanalytical Systems, Inc. (NASDAQ: BASI) Bioatla Inc (NASDAQ...
-
Vext Science Upsizes Bought Deal Public Offering To Raise $18M
2021 Jan 13, 1:31pm | 227Read More...Vertically integrated CBD company Vext Science Inc. (CSE: VEXT) (OTCQX: VEXTF) is poised to raise $18 million through a bought deal offering of its units. The Phoenix-based company confirmed Wednesday that Beacon Securities Ltd. will purchase some 16.1 million units of Vext Science ...
-
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
2021 Jan 13, 7:25am | 1873Read More...Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) AbbVie Inc (NYSE: ABBV) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) Aldeyra Therapeutics Inc (NASDAQ: ALDX) Alkermes Plc (NASDAQ: ALKS) AtriCure Inc...
